D.Western Therapeutics Institute, Inc. Logo

D.Western Therapeutics Institute, Inc.

Biotech firm discovering and licensing drug candidates, focusing on kinase inhibitors.

4576 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
名古屋市中区錦一丁目18番11号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

D.Western Therapeutics Institute, Inc. is a university-originated biotechnology venture focused on drug discovery and development. The company aims to create innovative and more effective drugs for patients worldwide by leveraging its core technology, which includes a proprietary compound library and specialized expertise in inhibitors, particularly protein kinases. Its business model centers on discovering and developing novel drug candidates before out-licensing them to larger pharmaceutical companies for late-stage clinical trials and commercialization. The company's development pipeline includes therapeutic drugs for various conditions, with a known focus in areas such as ophthalmology.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for D.Western Therapeutics Institute, Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-08-14 08:45
Interim Report
半期報告書-第28期(2025/01/01-2025/12/31)
Japanese 175.2 KB
2025-08-14 08:45
Regulatory News Service
確認書
Japanese 8.2 KB
2025-07-15 08:30
Prospectus
有価証券届出書(組込方式)
Japanese 540.8 KB
2025-03-26 01:26
Regulatory News Service
臨時報告書
Japanese 25.8 KB
2025-03-25 07:31
Regulatory News Service
確認書
Japanese 8.2 KB
2025-03-25 07:30
Regulatory News Service
内部統制報告書-第27期(2024/01/01-2024/12/31)
Japanese 21.5 KB
2025-03-25 07:30
Annual Report
有価証券報告書-第27期(2024/01/01-2024/12/31)
Japanese 1.1 MB
2025-01-16 07:34
Regulatory News Service
臨時報告書
Japanese 18.4 KB
2025-01-10 02:55
Regulatory News Service
臨時報告書
Japanese 21.1 KB
2024-08-09 08:35
Regulatory News Service
確認書
Japanese 8.2 KB
2024-08-09 08:34
Interim Report
半期報告書-第27期(2024/01/01-2024/12/31)
Japanese 219.2 KB
2024-06-07 08:31
Regulatory News Service
臨時報告書
Japanese 19.3 KB
2024-05-17 08:01
Prospectus
有価証券届出書(組込方式)
Japanese 328.7 KB
2024-05-13 08:32
Regulatory News Service
確認書
Japanese 8.1 KB
2024-05-13 08:31
Quarterly Report
四半期報告書-第27期第1四半期(2024/01/01-2024/03/31)
Japanese 135.5 KB

Automate Your Workflow. Get a real-time feed of all D.Western Therapeutics Institute, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for D.Western Therapeutics Institute, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
BrightBid Group Logo
AI SaaS platform automating paid search & shopping ads for businesses to maximize ROI.
Sweden BRIGHT
Developing novel cancer immunotherapies, including peptide vaccines and iPS-NKT cell therapies.
Japan 4594
Brilliant Future AB Logo
A data-driven survey platform to measure and improve employee & customer experiences.
Sweden BRILL
b-style holdings,Inc. Logo
Offers flexible staffing for homemakers and specialized recruitment for skilled professionals.
Japan 302A
BTS Group Logo
Helps organizations execute strategy via experiential learning for leadership and sales teams.
Sweden BTS
Advancing high-grade copper and precious metal projects from discovery to production.
Canada N/A
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572

Talk to a Data Expert

Have a question? We'll get back to you promptly.